RPS6 and acute lymphoblastic leukemia: Furthermore, flow cytometric analysis revealed that NSP‐B treatment markedly diminishes the phosphorylation levels of S6, a downstream target of mTORC1, signifying an overall downregulation of mTOR signalling in T‐ALL cells.